Advertisement

Obesity in Pregnancy: Data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

  • Harold David McIntyre
  • Lynn P. Lowe
  • Alan R. Dyer
  • Boyd E. Metzger
Chapter

Abstract

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has provided an opportunity to assess the relative associations of maternal glycemia measured at an oral glucose tolerance test (mean 28 weeks gestation) and maternal body mass index with a range of adverse pregnancy outcomes, without many of the potential confounding factors seen in previous studies. The HAPO study confirmed independently significant associations between maternal BMI and birthweight >90th centile, frequency of primary cesarean section, neonatal hypoglycemia, neonatal hyperinsulinemia, preeclampsia, and neonatal adiposity. The combination of maternal obesity and gestational diabetes was associated with higher frequencies of adverse outcomes than either variable in isolation.

Keywords

Body Mass Index Pregnancy Outcome Oral Glucose Tolerance Test Maternal Body Mass Index Oral Glucose Tolerance Test Result 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors acknowledge the HAPO Study Steering Committee for their assistance in the final reviews of this document.

References

  1. Baeten JM, Bukusi EA, Lambe M (2001) Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91:436–440PubMedCrossRefGoogle Scholar
  2. Bianco AT, Smilen SW, Davis Y, Lopez S, Lapinski R, Lockwood CJ (1998) Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol 91:97–102PubMedCrossRefGoogle Scholar
  3. Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20:IX–XIVPubMedGoogle Scholar
  4. Callaway LK, Prins JB, Chang AM, McIntyre HD (2006) The prevalence and impact of overweight and obesity in an Australian obstetrics population. Med J Aust 184:56–59PubMedGoogle Scholar
  5. Callaway LK, Colditz PB, Byrne NM, Lingwood BE, Rowlands IJ, Foxcroft K, McIntyre HD (2010) Prevention of gestational diabetes: feasibility issues for an exercise intervention in obese pregnant women. Diabetes Care 33(7):1457–1459PubMedCrossRefGoogle Scholar
  6. Carpenter MW, Canick JA, Star J, Carr SR, Burke ME, Shahinian K (1996) Fetal hyperinsulinism at 14–20 weeks and subsequent gestational diabetes. Obstet Gynecol 87:89–93PubMedCrossRefGoogle Scholar
  7. Catalano PM, Thomas AJ, Avallone DA, Amini SB (1995) Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol 173(4):1176–1181Google Scholar
  8. Dodd JM, Grivell RM, Crowther CA, Robinson JS (2010) Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials. BJOG 117:1316–1326PubMedCrossRefGoogle Scholar
  9. Ehrenberg HM, Mercer BM, Catalano PM (2004) The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 191:964–968PubMedCrossRefGoogle Scholar
  10. HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes 58:453–459CrossRefGoogle Scholar
  11. HAPO Study Cooperative Research Group (2010) Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study: associations with maternal body mass index. BJOG 117:575–584CrossRefGoogle Scholar
  12. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002PubMedCrossRefGoogle Scholar
  13. IADPSG Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefGoogle Scholar
  14. Institute of Medicine (Us) and National Research Council (Us) Committee to Reexamine Iom Pregnancy Weight Guidelines (2009) Weight gain during pregnancy: reexamining the guidelines. National Academies Press (US), Washington (DC)Google Scholar
  15. Kumari AS (2001) Pregnancy outcome in women with morbid obesity. Int J Gynaecol Obstet 73:101–107PubMedCrossRefGoogle Scholar
  16. Langer O, Yogev Y, Xenakis EMJ, Brustman L (2005) Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol 192:1768–1776PubMedCrossRefGoogle Scholar
  17. Leikin E, Jenkins JH, Graves WL (1987) Prophylactic insulin in gestational diabetes. Obstet Gynecol 70:587–592PubMedGoogle Scholar
  18. lowe LP, Metzger BE, Lowe WL Jr, Dyer AR, McDade TW, McIntyre HD (2010) Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. J Clin Endocrinol Metab 95:5427–5434PubMedCrossRefGoogle Scholar
  19. McIntyre HD, Chang AM, Callaway LK, Cowley DM, Dyer AR, Radaelli T, Farrell KA, Huston-Presley L, Amini SB, Kirwan JP, Catalano PM (2010) Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care 33:356–360PubMedCrossRefGoogle Scholar
  20. Metzger BE, Contreras M, Sacks DA, Watson W, Dooley SL, Foderaro M, Niznik C, Polk DH, Bjaloncik J, Catalano PM, Fox S, Gullion L, Johnson C, Lindsay CA, Makovos H, Saker F, Carpenter MW, Somers MH, Amankwah KS, Chan PC, Kapur B, Kenshole A, Lawrence G, Matheson K, Mayes L, Owen H, Basdeo P, Cave C, Fenty G, Gibson E, Hennis A, Rotchell YE, Spooner C, Thomas HAR, Fox J, Hadden DR, Halliday H, Irwin J, Kearney O, McCance DR, Smye M, Traub AI, Cruickshank JK, Dry J, Holt AC, Khan F, Lambert C, Maresh M, Prichard F, van Haeften TW, van de Hengel AMR, Visser GHA, Zwart A, Chaovarindr U, Chotigeat U, Deerochanawong C, Panyasiri I, Sanguanpong P, Amichay D, Golan A, Marks K, Mazor M, Ronen J, Wiznitzer A, Chen R, Faktorovich A, Harel D, Hoter N, Pardo J, Bowling F, Cowley D, Liley HG, McIntyre HD, Morrison B, Tudehope D, Kong SL, Li CY, Ng KF, Ng PC, Rogers MS, Beverly J, Edgar M, Giles W, Gill A, Lowe J, Verma J, Koh A, Tan E, Teo CC, Rajadurai V, Wee HY, Yeo GSH, Coustan D, Haydon B, Alexander A, Attias-Raved O, Hod M, Oats JJN (2002) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Int J Gynecol Obstet 78:69–77CrossRefGoogle Scholar
  21. Metzger BE, Lowe LP, Dyer AR, Coustan DR, Hadden DR, Hod M, Oats JJN, Persson B, Trimble ER (2010) The Hyperglycemia & Adverse Pregnancy Outcome (HAPO) study: associations of higher levels of maternal glucose and BMI with macrosomia: an example of diabesity. American Diabetes Association Proceedings, Orlando, FLGoogle Scholar
  22. Pedersen J, Bojsen-Moller B, Poulsen H (1954) Blood sugar in newborn infants of diabetic mothers. Acta Endocrinol (Copenh) 15:33–52Google Scholar
  23. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 87:4231–4237PubMedCrossRefGoogle Scholar
  24. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, Herrera E (2008) Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31:1858–1863PubMedCrossRefGoogle Scholar
  25. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa E, Forti A, Spichler ER, Pousada JM, Teixeira MM, Yamashita T (2001) Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 24:1151–1155PubMedCrossRefGoogle Scholar
  26. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S (2001) Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 25:1175–1182PubMedCrossRefGoogle Scholar
  27. Sermer M, Naylor CD, Farine D, Kenshole AB, Ritchie JW, Gare DJ, Cohen HR, McArthur K, Holzapfel S, Biringer A (1998) The Toronto Tri-hospital gestational diabetes project. A preliminary review. Diabetes Care 21(Suppl 2):B33–B42PubMedGoogle Scholar
  28. Sewell MF, Huston-Presley L, Amini SB, Catalano PM (2007) Body mass index: a true indicator of body fat in obese gravidas. J Reprod Med 52:907–911PubMedGoogle Scholar
  29. Wolff S, Legarth J, Vangsgaard K, Toubro S, Astrup A (2008) A randomized trial of the effects of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant women. Int J Obes (Lond) 32:495–501CrossRefGoogle Scholar
  30. Yogev Y, Langer O (2008) Pregnancy outcome in obese and morbidly obese gestational diabetic women. Eur J Obstet Gynecol Reprod Biol 137:21–26PubMedCrossRefGoogle Scholar
  31. Yogev Y, Chen R, Hod M, Coustan D, Oats JJN, Mcintyre HD, Metzger B, Lowe LP, Dyer AR, Dooley SL, Trimble ER, McCance DR, Hadden DR, Persson B, Rogers MS (2010) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 202:255 e1–255 e7Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Harold David McIntyre
    • 1
  • Lynn P. Lowe
    • 2
  • Alan R. Dyer
    • 3
  • Boyd E. Metzger
    • 4
  1. 1.University of Queensland and Mater Medical Research InstituteSouth BrisbaneAustralia
  2. 2.Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  4. 4.Division of Endocrinology, Metabolism & Molecular MedicineNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations